Dan Oren, 10% Owner at Protalix BioTherapeutics, Inc. (PLX), sold 1,837,434 shares at $2.56 ($4.2M) on 2021-06-02, disclosed to the SEC on 2021-06-03.
Open-market sale of $4.2M PLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.56 | 61,211 | $157K | 3.8% |
| 2 | $2.56 | 61,211 | $157K | 3.8% |
| 3 | $2.25 | 857,506 | $1.9M | 46.2% |
| 4 | $2.25 | 857,506 | $1.9M | 46.2% |
| Total | $2.27 avg | 1,837,434 | $4.2M | 100% |